T1 Level 1262 1282 benign Rama 37 cells
T2 Intervention 818 830 cellular OPN
T3 Protein 1559 1562 OPN
T4 Level 1216 1225 malignant
T5 Biomarker 1055 1065 MDA-MB-231
T6 Intervention 185 194 antitumor
T7 Intervention 51 61 neoplastic
T8 Condition 1102 1106 cell
T9 CL 1581 1608 OPN-mediated malignant cell
T10 Level 987 1020 R37 OPN pBK-CMV and C9 cell lines
T11 Protein 1167 1170 RNA
T12 Level 1740 1753 causing cells
T13 Protein 1203 1206 RNA
T14 Intervention 538 542 skin
T15 Protein 1226 1234 invasive
T16 Protein 890 907 β-catenin protein
T17 Condition 468 472 cell
T18 Intervention 240 249 cisplatin
T20 Protein 827 830 OPN
T21 Condition 544 549 colon
T22 Condition 339 361 human tumor cell lines
T23 Condition 1010 1014 cell
T24 Biomarker 842 847 Tcf-4
T25 Condition 1277 1281 cell
T26 Protein 10 20 inhibitors
T27 Protein 646 649 OPN
T28 Protein 1445 1454 β-catenin
T29 Level 646 719 OPN-mediated malignant transformation using mammary epithelial cell lines
T30 Condition 818 822 cell
T31 Protein 890 899 β-catenin
T32 Intervention 444 453 cisplatin
T33 Condition 1748 1752 cell
T34 Protein 1581 1584 OPN
T35 Protein 24 35 osteopontin
T36 Biomarker 154 170 oroidin alkaloid
T37 Biomarker 1158 1163 Tcf-4
T38 Level 1594 1603 malignant
T39 Intervention 1633 1639 colony
T40 Condition 351 355 cell
T42 Condition 1633 1638 colon
T43 Condition 1070 1112 MDA-MB-435s human breast cancer cell lines
T44 Condition 1787 1791 cell
T45 Condition 1718 1722 cell
T46 Protein 764 767 OPN
T47 Level 659 668 malignant
T48 Biomarker 1501 1506 Tcf-4
T49 Condition 709 713 cell
T50 Protein 991 994 OPN
T51 Protein 37 40 OPN
T52 Condition 555 572 breast carcinomas
